We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Zebrafish Model Provides Clues to Arterial Development

By Biotechdaily staff writers
Posted on 19 Jun 2003
Researchers have utilized transgenic zebrafish embryos with fluorescently labeled blood vessels to identify and characterize a mutant fish (y10) that lacks the gene for synthesis of phopholipase C gamma-1 protein (Plcg1) and displays specific defects in the formation of arteries but not veins.

Investigators at the US National Institutes of Health (Bethesda, MD, USA) worked with transparent zebrafish embryos, a well-established model system for development of vertebrates. More...
By labeling blood vessels with a fluorescent marker they could observe vessel formation during development. Their report in the June 1, 2003, issue of Genes & Development described the y10 mutant, which appeared to lack arteries but had ostensibly normal veins. The gene responsible for the y10 mutant phenotype was found to code for Plcg1, a known effector of receptor tyrosine kinase signaling found in a number of vertebrate species, including mammals.

The y10 mutant embryos failed to respond to added vascular endothelial growth factor (Vegf), indicating that Plcg1 functioned specifically downstream of the Vegf receptor during embryonic development to govern formation of the arterial system.

First author Dr. Nathan Lawson, now an assistant professor of molecular medicine at the University of Massachusetts Medical School (Worcester, USA; www.umassmed.edu) explained, "Until recently, we really did not know what the signals were that determined artery and venous identity, or even that this process was governed by genetic signals. It was always thought that circulatory flow and pressure caused a blood vessel to be an artery or a vein. I think an important implication of this work is that the signals that drive this process appear to be the same in fish and mammals. For that reason we think it is likely that what we learn about zebrafish blood vessels may help us manipulate the growth of human blood vessels in a variety of disease processes, including diabetes and cancer.”





Related Links:
National Institutes of Health
University of Massachusetts Medical School

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Electrolyte Analyzer
BKE-B
New
Automated Immunoassay Analyzer
SuperFlex™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.